Table 2: Summary of WHO Position Papers - Recommended ...
2 Hepatitis B • Position paper reference: Weekly Epid. Record (2017, 92:369-392) [pdf 2.4MB] • Hepatitis B vaccination is recommended for all children worldwide. Reaching all children with at least 3 doses of hepatitis B vaccine should be the standard for …
Download Table 2: Summary of WHO Position Papers - Recommended ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Updated Vaccine Guideline for Dialysis and Chronic Kidney ...
www.cdc.govthe vaccine series by using a method that allows determination of a protective level of anti-HBs (e.g., >10 mIU/mL). "Persons found to have anti-HBs levels of <10 mIU/mL after the primary vaccine series should be revaccinated with a second hepatitis B vaccination series. Administration of three or four
Blood/Body Fluid Exposure Option - Centers for Disease ...
www.cdc.govJan 01, 2013 · Blood/Body Fluid Exposure Option Last Updated January 1, 2013 3-3 • Non-intact skin exposure: Contact of non-intact skin with the fluids, tissues, or specimens listed below in "Occupational exposure." • Non-Responder to Hepatitis B vaccine: A HCW who has received two series of hepatitis B vaccine is serotested within 2 months after the last dose of vaccine …
Hepatitis A and Hepatitis B Vaccines: Be Sure Your ...
www.immunize.org0, 1, and 6 months. For Heplisav-B, use the standard dose (0.5 mL) and schedule (2 doses, 1 month apart). 5 When using HepB at birth and 3 doses of Pediarix, you will be administering 4 doses of HepB which is recommended by . ACIP. Hepatitis B …